Anti-TNFSF2/TNFa Antibody (Infliximab)
Catalog No.
F1050
Anti-TNFSF2/TNFa Antibody (Infliximab)
Featured Products
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab blocks the interaction of TNF-α with TNF-α receptor 1 (TNFR1) and TNFR2. Infliximab is used in the study of autoimmunity, chronic inflammatory diseases, and diabetic neuropathy.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.98 kDa
Dry ice
170277-31-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TA-650, Remicade
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01375
Human, Gorilla
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human TNFa, Fc Tag at 2 ug/mL can bind Anti-TNFSF2/TNFa Antibody (Infliximab)
TNFSF2 / TNFa
Please avoid freeze-thaw cycles.